Gene Frontier

GFC Focuses on Biopharmaceutical R&D Support, Providing Innovative Products and Services, Particularly Protein-Based Biologics, Including Antibodies. GFC Is Researching the Next Era of Antibody Therapies in Biologics. GFC Is Developing Its Own Antibody Therapies and New Technologies Beyond Antibodies, Such as Scaffolds. The Company Is Committed to Exploring the Potential of Protein-Based Biologics and Contributing to the Development of Innovative Therapies.